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Noncoding RNAs play important roles in various aspects of gene regulation. We have identiﬁed 7SK RNA to be enriched
in nuclear speckles or interchromatin granule clusters (IGCs), a subnuclear domain enriched in pre-mRNA processing
factors. 7SK RNA, in association with HEXIM 1 and 2, is involved in the inhibition of transcriptional elongation by RNA
polymerase II. Inhibition occurs via sequestration of the active P-TEFb kinase complex (CDK 9 and Cyclin T1/T2a/b or K)
that is involved in phosphorylating the C-terminal domain of RNA polymerase II. Our results demonstrate that
knock-down of 7SK RNA, by speciﬁc antisense oligonucleotides, results in the mislocalization of nuclear speckle
constituents in a transcription-dependent manner, and the transcriptional up-regulation of a RNA polymerase II tran-
scribed reporter gene locus. Furthermore, 7SK RNA transiently associates with a stably integrated reporter gene locus
upon transcriptional down-regulation and its presence correlates with the efﬁcient displacement of P-TEFb constituents
from the locus. Our results suggest that 7SK RNA plays a role in modulating the available level of P-TEFb upon
transcriptional down-regulation by sequestering its constituents in nuclear speckles.
INTRODUCTION
The eukaryotic cell nucleus is a membrane-bounded or-
ganelle where many critical cellular functions are carried out
within macromolecular protein complexes (reviewed in
Prasanth and Spector, 2005). To efﬁciently carry out these
functions, the mammalian cell nucleus is compartmental-
ized into speciﬁc subnuclear domains or nuclear bodies
(reviewed in Spector, 2006; Matera et al., 2009). Nuclear
bodies are broadly characterized by their macromolecular
composition, number, size, and associated functions. The
majority of nuclear bodies show little (PML bodies and Cajal
bodies) to no mobility in the nucleus (Muratani et al., 2002;
Platani et al., 2002). However, the proteins in these domains
generally show high levels of exchange between the do-
mains and the surrounding interchromatin space (reviewed
in Misteli, 2001; Misteli, 2008). In addition to their protein
constituents, some of these subnuclear domains also harbor
RNA molecules (reviewed in Prasanth and Spector, 2007;
Wilusz et al., 2009).
Recent large-scale genomic sequencing analyses have re-
vealed that human and mouse bear very similar number of
protein coding genes (23,000), surprisingly this number is
not very different from Caenorhabditis elegans (20,000) or
Drosophila (14,000) (www.ensembl.org). This suggests that
the complexity associated with higher organisms is not
solely related to the number of protein coding genes that
they harbor (reviewed in Mattick, 2001; Frith et al., 2005;
Mattick and Makunin, 2006; Kapranov et al., 2007; Pheasant
and Mattick, 2007; Prasanth and Spector, 2007; Wilusz et al.,
2009). Posttranscriptional modiﬁcations such as alternative
pre-mRNA splicing and RNA editing, as well as posttrans-
lational modiﬁcations of proteins, including phosphoryla-
tion, sumoylation, and ubiquitylation, can increase the pro-
teome size, but this is unlikely to fully account for the
complexity associated with higher eukaryotes (reviewed in
Prasanth and Spector, 2007). Interestingly, transcriptome
analysis has revealed that in human cells, a large fraction of
the genome is transcribed into RNA, whereas the protein
coding part comprises 5% of the genome (reviewed in
Mattick and Makunin, 2006; Willingham and Gingeras, 2006;
Kapranov et al., 2007; Prasanth and Spector, 2007; Wilusz et
al., 2009). Sequence annotation of these transcripts has re-
vealed that most if not all of these RNAs do not encode for
proteins and are therefore classiﬁed as noncoding RNA
(ncRNAs) or transcripts of unknown functions (TUFs) (re-
viewed in Mattick and Makunin, 2006; Willingham and
Gingeras, 2006; Kapranov et al., 2007; Prasanth and Spector,
2007; Wilusz et al., 2009). Some of the ncRNAs are expressed
in all cell types and are involved in executing essential
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4184housekeeping functions whereas a large proportion of them
show tissue or cell-type speciﬁc expression and are sug-
gested to be regulatory in nature (reviewed in Prasanth and
Spector, 2007; Wilusz et al., 2009). Altered expression of
some of these regulatory ncRNA transcripts has been di-
rectly implicated in various diseases including cancer and
neurological disorders (reviewed in Costa, 2005; Szymanski
et al., 2005; Calin and Croce, 2006; Costa, 2007; Prasanth and
Spector, 2007; Taft et al., 2009). It has been proposed that the
large number of regulatory RNAs present in higher eu-
karyotes contributes to the complex network that governs
cellular functions (reviewed in Mattick, 2001, 2004a; Mattick,
2005; Mattick and Makunin, 2006).
Interestingly, a subset of ncRNAs [examples include
snRNAs, snoRNAs, scaRNAs, MEN epsilon/beta (NEAT1),
Air, Gomafu, TERRA] is retained in the nucleus and local-
izes to speciﬁc nuclear bodies (reviewed in Prasanth and
Spector, 2007; Wilusz et al., 2009). It is hypothesized that
many yet to be identiﬁed ncRNAs may also be involved in
modulating vital gene regulatory pathways or act as struc-
tural components of some of the subnuclear domains (Pras-
anth et al., 2005; Pang et al., 2007; Prasanth and Spector, 2007;
Amaral et al., 2008; Dinger et al., 2008; Mercer et al., 2008;
Dinger et al., 2009; Mattick, 2009; Mercer et al., 2009; Pang et
al., 2009). For example, the recently identiﬁed nuclear-re-
tained ncRNAs; MEN epsilon/beta or NEAT1 play a crucial
role in establishing and maintaining paraspeckle integrity in
mammalian cells (Chen and Carmichael, 2009; Clemson et
al., 2009; Sasaki et al., 2009; Sunwoo et al., 2009).
Of particular interest in the present study is the popula-
tion of unidentiﬁed nuclear RNA/s that are enriched in
nuclear speckles or interchromatin granule clusters (IGCs)
(Carter et al., 1991; Huang et al., 1994; Lamond and Spector,
2003; Hall et al., 2006; Hutchinson et al., 2007). Nuclear
speckles are thought to be storage/modiﬁcation/assembly
centers for factors involved in pre-mRNA processing and
factors are recruited from speckles to active transcription
sites in a phosphorylation-dependent manner (reviewed in
Misteli and Spector, 1997; Lamond and Spector, 2003; Hall et
al., 2006). MALAT1 (Metastasis-associated lung adenocarci-
noma transcript 1), also known as NEAT2 (Hutchinson et al.,
2007), is a long (6.7 kb) ncRNA (Wilusz et al., 2008) that is
misregulated in many human cancers (Ji et al., 2003; Lin et al.,
2006) and was previously shown to be speciﬁcally retained
in nuclear speckles (Hutchinson et al., 2007). However,
knock-down of MALAT1 did not result in reorganization of
nuclear speckles indicating that MALAT1 is not a structural
RNA (Hutchinson et al., 2007; Clemson et al., 2009; Sasaki et
al., 2009).
Here, we demonstrate by RNA-FISH that 7SK RNA, a
331-nt long, highly conserved, small nuclear RNA, is en-
riched in nuclear speckles where it colocalizes with pre-
mRNA splicing factors. Knock-down of 7SK RNA in human
cells resulted in the disorganization of various splicing fac-
tors from IGCs in a transcription-dependent manner. Using
a stably integrated in vivo reporter cell line system we show
that knock-down of 7SK RNA results in increased expres-
sion of the reporter gene as well as efﬁcient recruitment of
various pre-mRNA processing factors to the transcription-
ally active gene locus. Furthermore, 7SK RNA transiently
associated with the reporter gene locus upon transcriptional
down-regulation, and its presence correlated with the displace-
ment of P-TEFb constituents from the locus. Based upon these
data we propose that 7SK RNA negatively regulates RNA pol
II transcription by facilitating the displacement of P-TEFb com-
ponents from the site of transcription, and sequestering them in
nuclear speckles, thereby contributing to the regulation be-
tween gene expression and silencing.
MATERIALS AND METHODS
Cell Culture and Drug Treatment
HeLa and U2OS cells were grown in DMEM containing high glucose (Invitro-
gen, Carlsbad, CA) supplemented with penicillin-streptomycin and 10% fetal
bovine serum (Hyclone Laboratories, Logan, UT). In addition, U2OS 2-6-3
tet-OFF and U2OS 2-6-3-TOLC cells were cultured in DMEM  10% Tet
system-approved FBS (BD Biosciences, Clontech, USA) in the presence of
hygromycin (100 g/ml) and G418 (600 g/ml).
To inhibit RNA polymerase II–mediated transcription, HeLa cells were
treated with -amanitin (50 g/ml) for5ha t37°C in the CO2 incubator. To
induce transcription from the artiﬁcial locus in U2OS 2-6-3-TOLC cells, cells
were treated with Doxycycline (DOX; 1 g/ml) for various time points.
Similarly, DOX was added to inhibit transcription from the locus in U2OS
2-6-3 tet-OFF cells.
Plasmid Constructs and DNA Transfection
Human 7SK promoter and coding region (Murphy et al., 1987) was PCR
ampliﬁed and was cloned into pEYFP-N1 vector (BD Biosciences Clontech,
Palo Alto, CA). The EYFP coding region was removed from the pEYFP-N1
vector during cloning. Next, a 6 repeat of the MS2 binding stem loop was
subcloned in between the 7SK promoter and coding region. MS2-BP-YFP
(Janicki et al., 2004) with the human pol II promoter was subcloned into
pVitro-Tn5; pVitro-MS2-BP-YFP (Invitrogen, San Diego, CA). Finally, the
7SK-6xMS2 stemloop region, with native promoter, was subcloned into
pVitro-MS2-YFP-NLS; pVitro-MS2-BP-YFP-7SK-6xMS2.
Plasmid DNAs (pVitro-MS2-BP-YFP-7SK-6xMS2, YFP-SF2/ASF, MS2-BP-
YFP, LacI-YFP, LacI-CFP, YFP-SC35, U2AF65-CFP, U1-70K-CFP (2 g/exper-
iment) were individually transfected into cells either by electroporation or by
lipid-based transfection (Lipofectamine-2000; Invitrogen, Carlsbad, CA). Af-
ter electroporation, cells were seeded onto acid-washed coverslips and pro-
cessed for immunoﬂuorescence localization or RNA ﬂuorescence in situ hy-
bridization 24 h posttransfection.
Immunoﬂuorescence
Cells were rinsed brieﬂy in phosphate-buffered saline (PBS) and then ﬁxed for
15 min in 1.7% formaldehyde in PBS (pH 7.4). Cells were permeabilized in
PBS containing 0.5% Triton X-100 and 1% goat serum for 7–10 min on ice,
washed in PBS NGS, and were incubated with primary antibodies (anti-
SC35 [1:200] (Fu and Maniatis, 1990), anti-SF2/ASF [1:200; gift from Dr.
Adrian Krainer, CSHL, USA], anti-B” [1:50] (Habets et al., 1985), anti-CDK9
[1:100] and anti-Cyclin-T1 [1:100] (Santa Cruz Biotechnology, Santa Cruz,
CA), anti-RNA pol II [H14; 1:20]) (Bregman et al., 1995) for1ha troom
temperature. Cells were rinsed in PBS containing 1% goat serum and then
secondary anti–species-speciﬁc antibodies (Jackson Immunoresearch Labora-
tories, West Grove, PA) were added for 30 min at room temperature: goat
anti-rabbit (GAR) IgG1-Texas Red (1:1000), GAM IgG Texas Red (1:1000), goat
anti-rabbit (GAR) IgG1-FITC (1:1000). DNA was stained with 4,6-diamidino-
2-phenylindole (DAPI). Cells were mounted in medium containing 90% glyc-
erol, 10% PBS pH 8.0 plus 1 mg/ml paraphenylenediamine. Cells were
examined using an Axioplan 2i ﬂuorescence microscope (Carl Zeiss, Thorn-
wood, NY) equipped with Chroma ﬁlters (Chroma Technology, Brattleboro,
VT). OpenLab software (Improvision, Boston, MA) was used to collect digital
images from an ORCA cooled charge-coupled device camera (Hamamatsu,
Bridgewater, NJ). Images were also acquired using a DeltaVision deconvolu-
tion microscope system and softWoRx 2.50 software (Applied Precision,
Issaquah, WA).
RNA-Fluorescence In Situ Hybridization (RNA-FISH)
To detect 7SK-RNA, cells were rinsed brieﬂy in PBS, ﬁxed in 2% formalde-
hyde in PBS (pH 7.4) for 15 min at RT. Cells were permeabilized in PBS
containing 0.5% Triton X-100 and 5 mM VRC (New England Biolabs, Beverly,
Massachusetts) on ice for 5–10 min. Cells were washed in PBS 3 times 10 min
each and rinsed once in 2 SSC before hybridization. Hybridization was
carried out using a Texas Red conjugated 24-mer DNA oligodeoxynucleotide
probe (5-cagatgagccgaatcaaccctggc-3) complementary to 7SK RNA in a
moist chamber at 42°C for 12–16 h as described earlier (Prasanth et al., 2005).
Total poly(A) RNA was visualized by RNA-FISH using a ﬂuorescently-
labeled oligo dT probe (Huang et al., 1994). For co-RNA-FISH and immuno-
localization studies, after RNA-FISH, cells were again ﬁxed for 5 min in 2%
formaldehyde, and IF and imaging were performed as described earlier
(Prasanth et al., 2003; Prasanth et al., 2005).
Antisense-Oligonucleotide Treatment
Phosphorothioate-modiﬁed DNA antisense oligodeoxynucleotides targeting
7SK RNA (AS99: CCTTGAGAGCTTGTTTGGAGG; AS94: CTAGCCAGCCA-
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(Prasanth et al., 2005). Antisense DNA oligonucleotides (100 nM) were ad-
ministered to HeLa and U2OS cells using Lipofectamine 2000 or Lipo-
fectamine RNAiMax reagent as per the manufacturer’s instructions (Invitro-
gen, USA). Cells were treated with antisense oligonucleotides (2 times at an
interval of 24 h), were ﬁxed post-24 h after the second antisense treatment and
were processed for immunoﬂuorescence localization or RNA ﬂuorescence in
situ hybridization.
RESULTS
7SK RNA Localizes to Nuclear Speckles
By using an RNA-FISH based approach in human and
mouse cell lines, we have localized 7SK RNA in a ﬁne
punctate nuclear distribution, excluding the nucleoli, in
mouse NIH-3T3 cells, human HeLa (Figure 1Aa), and U2OS
cells. In addition, it was also enriched in 15–30 subnuclear
domains, reminiscent of nuclear speckles or IGCs (Figure
1Aa). Colocalization studies of 7SK RNA in HeLa cells ex-
pressing the SR family splicing factor EYFP-SF2/ASF (Bubu-
lya et al., 2004) conﬁrmed the localization of 7SK RNA to
nuclear speckles (Figure 1Aa–Ad). Furthermore, RNA-FISH
in cells that were pre-extracted with detergent to remove
most of the soluble homogenous pool of 7SK RNA showed
a more pronounced distribution of 7SK RNA in nuclear
speckles (data not shown). Pretreatment of cells with RNAse
A (data not shown) as well as knock-down of 7SK RNA
using multiple modiﬁed antisense oligonucleotides abol-
ished the 7SK RNA-FISH signal in the nuclear speckles
(Figure 2B & Supplemental Figure 1).
Nuclear speckles contain various pre-mRNA processing
factors and have been suggested to play a role in modulating
transcription and pre-mRNA splicing (reviewed in Lamond
and Spector, 2003; Hall et al., 2006). Treatment of cells with
RNA pol II inhibitors was previously shown to result in the
rounding up of nuclear speckles (Spector et al., 1983; Huang
et al., 1994). Incubation of YFP-SF2/ASF expressing HeLa
cells with the RNA pol II inhibitor -amanitin clearly
showed the enrichment of 7SK RNA in the rounded up
nuclear speckles (Figure 1B, a–d). It has previously been
demonstrated that only a fraction of the SR protein SF2/ASF
associates with rounded up nuclear speckles in transcrip-
tionally inhibited cells, whereas the rest of the pool localizes
around the nucleoli (Figures 1Bb and 3Ce) (Bubulya et al.,
2004). However, the distribution of 7SK RNA in -amanitin–
treated cells shows that it does not localize around nucleoli
and its distribution in RNA pol II–inhibited cells is very
similar to other known non-SR splicing factors (Figure 3, Cb
and Cf) (Bubulya et al., 2004).
We have also tagged the human 7SK RNA with bacterio-
phage MS2 stem-loop repeats (7SK-MS2) and transiently
expressed this construct with an MS2 binding protein-YFP
(MS2-BP-YFP) fusion protein in human cells. The cells that
expressed MS2-BP-YFP alone showed homogenous nuclear
staining of YFP, including in the nucleoli (data not shown).
However, cells that coexpressed both 7SK-MS2 and MS2-BP-
YFP showed a ﬁne punctate nuclear distribution of YFP. In
addition, prominent YFP signal was also enriched in nuclear
speckles as conﬁrmed by coimmunolocalization with an IGC
marker protein SC35 (Figure 1, Ca–Cc). From these results, it
is clear that a signiﬁcant fraction of the nuclear retained 7SK
RNA is localized to nuclear speckles.
7SK RNA Modulates the Distribution of Nuclear Speckle
Proteins
The involvement of nuclear retained 7SK RNA in transcrip-
tional regulation has been well documented (Blencowe,
2002; Peterlin and Price, 2006; Barrandon et al., 2008). In the
nucleus, 7SK facilitates the interaction of active P-TEFb with
HEXIM1 and/or 2. HEXIM proteins inactivate the kinase
activity of P-TEFb, which in turn inhibits RNA pol II tran-
scription elongation (Peterlin and Price, 2006; Barrandon et
al., 2008). Previous studies have reported the presence of
components of the P-TEFb complex (CDK9, Cyclin T1 and
HEXIM1) in nuclear speckles (Herrmann and Mancini, 2001;
Pendergrast et al., 2002; Haaland et al., 2005). However, we
were interested in examining whether 7SK RNA that local-
izes to nuclear speckles is part of the inactive P-TEFb kinase
Figure 1. 7SK RNA is enriched in nuclear
speckles. (Aa–Ad) Deconvolved images of
RNA-FISH performed on HeLa cells using a
7SK oligonucleotide probe reveals enrich-
ment of 7SK RNA (red, Aa) in nuclear speck-
les and colocalizes (Ac) with a known nuclear
speckle marker, SF2/ASF (green, Ab). (Ba–
Bd) Inhibition of RNA polymerase II by
-amanitin treatment shows 7SK RNA (red,
Ba) enrichment in rounded up nuclear speck-
les (Bc). (Ca–Cc) Transient expression of an
MS2 stem-loop tagged 7SK RNA (green, Ca)
and MS2-BP-YFP in live HeLa cells shows
colocalization of tagged 7SK RNA with SC35-
RFP (red, Cb) in nuclear speckles (merge, Cc).
DNA was stained with 4,6-diamidino-2-phe-
nylindole (DAPI) (blue, Ad, Bd). The scale bar
represents 10 m.
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organization of nuclear speckle constituents. To address the
role of 7SK in the subnuclear localization of pre-mRNA
splicing factors, the distribution of various nuclear speckle
components were examined in human cells after depletion
of 7SK RNA. More than 90% knock-down of 7SK RNA was
achieved by using modiﬁed antisense DNA oligonucleotides
(Figure 2, A and B). Two independent antisense oligonucle-
otides were used to target 7SK RNA and both showed
similar results (data not shown). Cells were analyzed for
7SK knock-down and for immunolocalization of various
nuclear speckle marker proteins 48 h post antisense oligo-
nucleotide treatment. In control oligonucleotide (scrambled
oligo) treated cells, YFP-SF2/ASF distributed in nuclear
speckles and colocalized with 7SK RNA (Figure 2B, a–b). In
cells that were depleted of 7SK RNA, YFP-SF2/ASF showed
a weak homogenous localization. Intriguingly, these cells
also showed 2–8 very prominently labeled round YFP-SF2/
ASF foci (Figure 2, Bc, Cd, Dc, and Ec) (number of nuclei
counted  1000). The appearance of the ‘SF2/ASF foci’ in
7SK-depleted cells served as a good marker to differentiate
cells showing efﬁcient knock-down of 7SK RNA. Similar
distribution was also observed with endogenous SF2/ASF,
as observed by immunostaining using SF2/ASF antibodies
(Supplemental Figure 1). Interestingly, several of the other
nuclear speckle-associated splicing factors (SC35, Figure 2C;
U2AF65, Supplemental Figure 2, A and C; U1-70K, Supple-
mental Figure 2, B and D) also formed prominent nuclear
foci in 7SK RNA depleted cells. Interestingly, none of these
nuclear foci colocalize with the SF2/ASF foci indicating that
they form independent foci and do not represent remnants
of nuclear speckles (Figure 2C, d–f). The prominent nuclear
foci observed in the 7SK depleted cells did not correspond to
rounded up nuclear speckles observed during transcription
inhibition, as these were fewer in number and also did not
contain all the other nuclear speckle proteins nor poly(A)
RNAs (Figures 2C, d–f, 2D, c–d, and 2E, c–d). In addition,
the SF2/ASF foci that appeared after 7SK RNA depletion
did not colocalize with any of the known subnuclear do-
mains including PML bodies and Cajal bodies (data not
Figure 2. Knock-down of 7SK RNA results
in the disorganization of nuclear speckle com-
ponents. (A) Antisense oligonucleotides de-
signed against 7SK RNA were used to knock-
down 7SK in HeLa cells. 90% knock-down
was achieved as assessed by Q-PCR. Control
oligonucleotide had no effect. 7SK RNA levels
were normalized to -actin mRNA and are
presented relative to RNA levels in scrambled
oligonucleotide transfected cells. The data are
shown as mean and SD values of three mea-
surements per data point. (B) YFP-SF2/ASF
(green, Ba) and 7SK RNA FISH (red, Bb) show
prominent colocalization in speckles in HeLa
cells treated with control antisense oligonu-
cleotides (control oligo). Antisense knock-
down of 7SK results in the appearance of
large intranuclear foci of SF2/ASF (green, Bc,
see arrowheads) and its disorganization from
speckles. (C) YFP-SF2/ASF (green, Ca) and
SC35 immunoﬂuorescence (red, Cb) show
prominent colocalization in speckles (merge,
Cc) in HeLa cells treated with scrambled an-
tisense oligonucleotides (control oligo). Anti-
sense knock-down of 7SK results in the ap-
pearance of large intranuclear foci of SF2/
ASF (green, Cd) and its disorganization from
speckles. The cell that shows SF2/ASF foci
also shows appearance of small rounded up
SC35 foci (see arrows, red, Ce). Interestingly,
both SF2/ASF and SC35 foci do not colocalize
(merge, Cf). (D) YFP-SF2/ASF (green, Da)
and immunolocalization of B” U2snRNP (red,
Db) show prominent colocalization at the
speckles in HeLa cells treated with control
antisense oligonucleotides (control oligo).
Cells lacking 7SK RNA demonstrate intranu-
clear foci of SF2/ASF (green, Dc). However,
B” U2 snRNP shows a more homogenous dis-
tribution but continues to localize in Cajal
bodies (red, Dd, see arrow). (E) RNA FISH
using oligo dT probes shows poly(A) RNA
enrichment in speckles of control oligonucle-
otide treated cells (red, Eb). In contrast, fol-
lowing 7SK knock-down poly (A) RNA ap-
pears as a more homogenous nuclear pool
(red, Ed). Scale bar represents 5 m.
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of the U2-snRNP complex, also showed a change in its
distribution in the 7SK-depleted cells. In control oligonucle-
otide-treated cells, B” localized in nuclear speckles and also
in Cajal bodies (Figure 2Db). In the 7SK-depleted cells, B”
localization in the nuclear speckles was less apparent, as
compared with control oligonucleotide-treated cells, and
showed a more homogenous distribution (Figure 2Dd).
However, the B” staining in the Cajal bodies remained un-
altered (see the arrow in Figure 2Dd). Together, these results
show that 7SK depletion changes the distribution of pre-
mRNA splicing factors between nuclear speckles and the
nucleoplasm, but not from other subnuclear structures (i.e.,
Cajal bodies). Interestingly, the poly(A)RNA pool that is
localized in nuclear speckles also showed a more homoge-
nous distribution with a few foci after 7SK RNA depletion
(Figure 2E, a–d) suggesting that the presence of 7SK RNA is
critical for appropriately maintaining the speckle constituents
in human cells. Importantly, immunoblot analysis from total
cell extracts revealed that the levels of various speckle compo-
nents including, B” U2snRNP, SF2/ASF, CDK9, and Cyclin T1
in control versus 7SK depleted samples were comparable (Fig-
ure 3B). This suggests that 7SK depletion alters the nuclear
distribution of nuclear speckle proteins without modulating
their total cellular levels.
Components of the inactive P-TEFb complex, CDK9, Cy-
clin-T1 and HEXIM1 have previously been reported to lo-
calize to nuclear speckles (Herrmann and Mancini, 2001;
Pendergrast et al., 2002; Haaland et al., 2005). Because 7SK
RNA is a part of the inactive P-TEFb complex, we were next
interested to address whether 7SK RNA plays any role in the
recruitment of these proteins to nuclear speckles. In cells
depleted of 7SK RNA, Cdk9 redistributed to nucleoli
whereas in control oligonucleotide-treated cells, it showed
more punctate nuclear distribution excluding nucleoli (Fig-
ure 3A).
Next, we examined whether the changes in distribution of
nuclear speckle components in 7SK RNA depleted cells were
sensitive to the overall transcriptional status of the cells. To
test this, we treated HeLa cells with or without 7SK RNA
with -amanitin to inhibit RNA pol II transcription and
compared the distribution of nuclear speckle proteins. In-
triguingly, no signiﬁcant difference in SF2/ASF and B” dis-
tribution was observed between 7SK RNA-depleted cells
and control oligonucleotide-treated cells (Figure 3C). From
these data we conclude that the changes in localization of
nuclear speckle proteins we observed in 7SK RNA-depleted
cells is sensitive to ongoing transcription.
Knock-Down of 7SK RNA Increases the Transcriptional
Output of a Stably Integrated Reporter Locus
7SK RNA is known to play a crucial role in the transcrip-
tional regulation of HIV viral RNAs (reviewed in Peterlin
and Price, 2006). We were interested to monitor whether
nuclear levels of 7SK RNA modulate cellular transcription.
To test this, we took advantage of a stably integrated in vivo
reporter cell line system where levels of gene expression at
a single genetic locus can be monitored in real-time (Janicki
et al., 2004; Shav-Tal et al., 2004). Tet-ON and LacI-mCherry
plasmids were stably integrated into the original U2OS 2-6-3
cell line (U2OS 2-6-3-TOLC; Figure 4A). U2OS 2-6-3-TOLC
cells were transiently transfected with MS2-BP-YFP, and its
recruitment was monitored at the locus during gene activa-
tion following doxycycline (DOX) treatment, in the presence
Figure 3. Displacement of splicing factors
from nuclear speckles upon 7SK depletion is
transcription dependent. (A) Immunoﬂuores-
cence localization of CDK9 (green, Aa) and
the hyperphosphorylated form of RNA pol II
(H14 ab, red, Ab) in control oligonucleotide
treated U2OS cell shows a punctate nuclear
localization excluding the nucleoli (arrow).
7SK antisense olgonucleotide-treated cell
shows a reorganization of the distribution of
CDK9 to nucleoli (green, Ac), whereas the
RNA pol II localization remains unaltered
(red, Ad). (B) Immunoblot analysis using an-
tibodies against P-TEFb components and
splicing factors in HeLa cells shows no
change in their levels in control versus 7SK
AS treated cells. (C) YFP-SF2/ASF (green, Ca)
and B” (red, Cb) localization in control oligo-
nucleotide treated HeLa cells followed by
-amanitin incubation shows that YFP-SF2/
ASF is enriched around the nucleoli whereas
B” protein localizes to the rounded up speck-
les (merge, Cc). -amanitin incubated 7SK an-
tisense oligonucleotide treated HeLa cells also
shows a similar distribution of YFP-SF2/ASF
and B” (Ce–Ch) indicating the disorganiza-
tion of splicing factors from nuclear speckles
observed in 7SK depleted cells is transcription
dependent. DNA is counterstained with
DAPI (blue, Cd, Ch). The bar indicates 10 m.
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control oligonucleotides, MS2-BP-YFP was recruited to the
transcriptionally active locus within 15 min post DOX addi-
tion (Figure 4Bc). Interestingly, in cells that were depleted of
7SK RNA, DOX treatment (15 min) resulted in an increased
accumulation of MS2-BP-YFP at the locus (Figure 4Bd). This
suggested that 7SK depletion increased the transcriptional
activity of the reporter gene. To conﬁrm this further, we
analyzed the levels of reporter RNA by RT-PCR (Figure 4C).
The primer pairs for the PCR were designed to differentiate
reporter mRNA from pre-mRNA based on the amplicon
size. An increased level of ampliﬁcation of reporter mRNA
was observed from total RNA of cells that were treated with
7SK antisense oligonucleotides compared with control oli-
gonucleotides (Figure 4C). Finally, a concomitant increase in
the levels of reporter Cyan ﬂuorescent protein (CFP) was
also observed in cells that were depleted of 7SK RNA (Fig-
ure 4D). From these results, it is clear that upon depletion of
7SK RNA, the reporter gene locus is hyperactivated and the
resulting transcripts are processed and translated efﬁciently
into protein.
Nuclear speckles play critical roles in modulating RNA
pol II–mediated transcription and pre-mRNA processing
(reviewed in Lamond and Spector, 2003), and disruption of
nuclear speckles in cells results in aberrant transcription and
pre-mRNA splicing (Sacco-Bubulya and Spector, 2002). De-
pletion of 7SK RNA resulted in the mislocalization of vari-
ous nuclear speckle-associated pre-mRNA splicing factors.
Therefore, we were interested to study whether 7SK RNA
depletion inﬂuences the recruitment of splicing factors to a
transcription site. We have analyzed the recruitment of YFP-
tagged SF2/ASF and SC35 to the DOX induced transcription
locus in U2OS 2-6-3-TOLC cells in the presence or absence of
7SK RNA. In control oligonuclotide-treated cells, both SC35
(Figure 5A, a–c) and SF2/ASF (Figure 5B, a–c) localized to
nuclear speckles and did not associate with the lacI-
mCherry-tagged transcriptionally inactive locus (Figure 5,
Ac and Bc). After addition of DOX to the medium (180
mins), both SC35 and SF2/ASF localized to the transcrip-
tionally active decondensed gene locus (Figures 5A, d–f and
5B, d–f). Both proteins continue to show nuclear speckle
association in DOX treated cells (Figures 5, Ad and Bd). In
Figure 4. 7SK depletion up-regulates reporter gene expression using the pTet-ON system. (A) Schematic representation of the reporter
construct used for the analysis. The arrows in the ﬁgure indicate the positions of the primer used for the RT-PCR analysis. The ﬁgure is
adapted and modiﬁed from (Janicki et al., 2004). (B) In control cells MS2-YFP localization shows an accumulation of the reporter RNA at the
site of transcription 15 min post gene activation (green, Bc, arrowhead). In the absence of 7SK RNA, higher levels of reporter RNA accumulate
at the transcription site (green, Bd, arrow). Scale bar represents 5 m. (C) RT-PCR analysis of RNA samples from cells isolated 15 min and
30 min post DOX treatment shows up-regulation of the reporter gene in cells that are depleted of 7SK RNA (D) Immunoblot analysis using
an anti-GFP antibody demonstrates the up-regulation of reporter CFP protein in 7SK knock-down cells corroborating the increased
transcriptional activation of the reporter gene in the absence of 7SK RNA. -tubulin was used as a loading control.
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ASF formed the prominent round nuclear foci (Figure 5A, g
and j and 5B, g and j). Interestingly, DOX-treated 7SK RNA–
depleted cells continue to show strong association of both
SC35 and SF2/ASF to the transcriptionally active locus (Fig-
ure 5A, j–l and 5B, j–l). These results imply that 7SK RNA
does not inﬂuence the recruitment of SR-splicing factors to
the transcription site.
pTEF-b Protein Constituents, but Not 7SK RNA, Are
Efﬁciently Recruited to the Transcribing Reporter Locus
It is known that P-TEFb phosphorylates serine 2 within the
carboxy-terminal domain (CTD) of RNA pol II, a posttrans-
lational modiﬁcation that is essential for efﬁcient transcrip-
tional elongation (Peterlin and Price, 2006; Zhou and Yik,
2006). We analyzed the recruitment of P-TEFb components
to the reporter gene locus during transcriptional activation.
When the locus was inactive, neither CDK9 (Figure 6A, a–c)
nor 7SK RNA (Figure 6Ba-c) was present at the locus. After
addition of DOX (240 min), CDK9 was efﬁciently recruited to
the actively transcribing locus (Figure 6C, a–c and 6E, a–d).
Similar results were also observed with cyclin T1 (data not
shown). However, we did not observe 7SK RNA at the
transcriptionally active locus (Figure 6D, a–c and 6F, a–d).
These results indicate that only CDK9 and CyclinT1, and not
7SK RNA, are recruited to the gene locus during active
transcription.
7SK RNA Transiently Associates with the Gene Locus
Upon Transcriptional Down-Regulation and Plays a Role
in the Displacement of P-TEFb from the Locus
7SK RNA is involved in the cessation of transcription of
cellular genes by facilitating the interaction of HEXIMs with
the CDK9/Cyclin T kinase complex (Peterlin and Price,
2006; Zhou and Yik, 2006; Barrandon et al., 2008). Because
7SK RNA was absent from the transcriptionally active locus,
we were interested in analyzing whether 7SK RNA associ-
ates with the gene locus during the inactivation process. We
used a U2OS 2-6-3 Tet-OFF cell line for this experiment,
where the reporter gene is active in the absence of DOX and
upon addition of DOX, it becomes inactivated. Within 5–10
min post DOX addition, transcription at the locus ceased
with a concomitant loss of detectable levels of CDK9 (Fig-
ures 7Db, 7Eb, and 8 and Supplemental Figure 3). Dual
RNA-FISH and immunolocalization analysis revealed the
presence of CDK9 in cells where the locus was transcription-
ally active (see arrowhead in Figure 7Ab). However, there
was no 7SK RNA associated with the active locus (Figure
7Ac). Surprisingly, within 2 min 30 s post-DOX addition,
7SK RNA was enriched at the locus, which also had CDK9
associated with it (arrowhead in Figure 7B, a–d). 7SK RNA
association with the locus was prominent 5 min post DOX
addition (arrowheads in Figure 7C, a–d and see inset in
Figure 7C, b–d). However, within 7.5–10 min post-addition
of DOX, 7SK RNA was no longer associated with the locus
(Figure 7, Dc and Ec). Interestingly, CDK9 also dissociated
from the locus concomitant with the disappearance of 7SK
RNA (Figure 7, Db and Eb). These data indicate that 7SK
RNA is transiently enriched at the reporter gene locus dur-
ing its transcriptional down-regulation. Interestingly, dur-
ing gene inactivation, the dissociation of 7SK RNA from the
locus coincided with the loss of CDK9 suggesting that this
transient association of 7SK RNA is likely crucial for the
efﬁcient displacement of P-TEFb constituents from the gene
locus.
To understand the role of 7SK RNA in the displacement
of Cdk9 from the locus during transcriptional inactiva-
tion, we examined the displacement kinetics of Cdk9 from
the locus in control and 7SK-depleted cells during tran-
scriptional inactivation. In a large fraction of control
oligo-treated cells (50%), Cdk9 was displaced from the
locus 10 min post-DOX addition (Figures 8, C and K).
However, the majority of 7SK-depleted cells, Cdk9 con-
tinued to associate with the locus even at 20 min post
DOX addition (Figures 8, I and K). These results indicate
that 7SK plays a critical role in the efﬁcient release or
displacement of CDK9 from the gene locus during tran-
scriptional inactivation.
Figure 5. The recruitment of SR-family splicing factors to a transcriptionally active locus remains unaffected in cells that are depleted
of 7SK RNA. In U2OS 2-6-3-TOLC cells, YFP-SC35 (A) and YFP-SF2/ASF (B) are recruited to the transcriptionally active locus ([] DOX,
Ad–f; Aj–l; Bd–f; Bj–l) in the presence (YFP-SC35, Ad–f; YFP-SF2/ASF, Bd–f) or absence (YFP-SC35, Aj–l; YFP-SF2/ASF, Bj–l) of 7SK
RNA. Note that the 7SK depleted cells show prominent round YFP-SC35 (Ag–l) and YFP-SF2/ASF (Bg–l) subnuclear foci. The scale bar
represents 10 m.
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7SK is a nuclear-retained ncRNA that executes a housekeep-
ing function in the cell by negatively regulating RNA pol
II–mediated transcriptional elongation (Nguyen et al., 2001;
Yang et al., 2001; Peterlin and Price, 2006). 7SK RNA is an
abundant (2  105 copies per cell), 331-nucleotide-long
RNA pol III–transcribed RNA that exhibits high sequence
conservation among vertebrates (Zieve and Penman, 1976;
Kruger and Benecke, 1987; Murphy et al., 1987; Wassarman
and Steitz, 1991). Biochemical and cell biological studies
have demonstrated that 7SK is a bonaﬁde nuclear RNA (Zieve
and Penman, 1976; Gurney and Eliceiri, 1980; Matera and
Ward, 1993). However, the precise localization of 7SK RNA
in the nucleus had not been clearly elucidated. A previous
study reported “a slightly speckled nucleoplasmic localiza-
tion” of 7SK RNA in human cells (Egloff et al., 2006). How-
ever, our RNA-FISH immunocytochemical analysis clearly
demonstrated the presence of a fraction of 7SK RNA in
nuclear speckles. Although speckles contain RNA, they are
not sites of active transcription and are located in interchro-
matin regions with little to no DNA (reviewed in Lamond
and Spector, 2003).
Previous studies have shown the presence of P-TEFb pro-
tein components (CDK9, CyclinT1 and HEXIM1) in nuclear
speckles (Herrmann and Mancini, 2001; Pendergrast et al.,
2002; Haaland et al., 2005). In HeLa cells, 50% of the
P-TEFb is thought to be sequestered into the large inactive
complex that also contains 7SK RNA, whereas the active
P-TEFb complex is localized at sites of gene transcription
(Yang et al., 2001; Michels et al., 2003; Yik et al., 2003; Byers et
al., 2005; Yik et al., 2005; Michels and Bensaude, 2008). Be-
cause speckles do not correspond to active sites of transcrip-
tion, the P-TEFb components present in speckles may pro-
vide a mechanism by which 7SK RNA can sequester the
P-TEFb complex away from transcription sites. Our ﬁnding
of an increased level of 7SK in nuclear speckles upon tran-
scriptional inhibition and P-TEFb components (Herrmann
and Mancini, 2001) further corroborates this possibility. In
contrast, biochemical studies have revealed that in response
to transcription inhibition, 7SK RNA and HEXIM proteins
disassociate from the P-TEFb complex (Nguyen et al., 2001;
Yang et al., 2001; Michels et al., 2003; Yik et al., 2003) and 7SK
RNA shows increased association with different sets of pro-
teins including hnRNPs (Barrandon et al., 2007; Hogg and
Collins, 2007; Van Herreweghe et al., 2007). However, this
Figure 6. P-TEFb, but not 7SK, is present at
sites of active transcription of a stably inte-
grated reporter locus. (A and B) Immunolo-
calization to CDK9 (red, Aa) and 7SK RNA-
FISH (red, Ba) in U2OS 2-6-3 tet-ON cells.
These constituents (Ac, Bc) are not visualized
at the inactive locus (LacI-YFP, green, Ab and
Bb). (C and D) 240 min after Dox addition and
induction of transcription CDK9 (red, Ca), but
not 7SK RNA (red, Da), is concentrated at the
active locus (green, Cb and Db). While CDK9
(Cc) shows direct overlap with decondensed
chromatin, 7SK RNA (Dc) is absent from the
region. (E and F) CDK9 (red, Ea) but not 7SK
RNA (red, Fa) is enriched at the actively tran-
scribing reporter gene locus (green, Eb and
Fb) as observed by MS2-YFP bound to nas-
cent RNA (Ec and Fc). DNA is counterstained
with DAPI (blue, Ed, Fd). Scale bar represents
10 m.
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system. Our data suggest that 7SK RNA sequesters compo-
nents of P-TEFb in nuclear speckles, and when required
these factors are relocalized to the transcription sites for
gene activation. This suggests yet another important func-
tion for nuclear speckles in regulating gene expression by
modulating the levels of active P-TEFb complex in the nu-
cleoplasm.
The changes in the distribution of nuclear speckle com-
ponents in cells depleted of 7SK RNA indicates another
potential role for 7SK RNA in organizing nuclear speckle
constituents. RNA pol II transcription inhibition as well as
pre-mRNA splicing inhibition is known to affect speckle
morphology (reviewed in Lamond and Spector, 2003). The
reporter cell line studies clearly indicate that 7SK knock-
down does not inhibit transcription and constitutive splicing
of pre-mRNAs at the reporter gene locus (Figure 4) and the
pattern of distribution of splicing factors observed after 7SK
RNA depletion is quite different from what is observed after
inhibition of transcription or splicing (Spector et al., 1983;
O’Keefe et al., 1994). It is also unlikely that 7SK RNA has a
structural role in maintaining the integrity of nuclear speck-
les. It is known that hyper-phosphorylation of SR-splicing
factors (examples include SF2/ASF and SC35) by SR protein
kinases disrupt the nuclear speckles and such studies failed
to observe any organized underlying nuclear skeleton sta-
bilizing nuclear speckles supporting the conclusion that
RNA(s) is not likely providing the structural framework for
speckle organization (Sacco-Bubulya and Spector, 2002). We
speculate that depletion of 7SK RNA in cells increases total
RNA pol II transcription, which in turn affects the intracel-
lular distribution of pre-mRNA processing factors by re-
cruiting them from nuclear speckles to transcription sites.
Previous studies have also indicated increased CDK9 activ-
ity and hyperactivation of reporter genes in cells that were
depleted of 7SK RNA (Yang et al., 2001; Haaland et al., 2005).
Disassociation of 7SK RNA from the P-TEFb complex by
depletion of 7SK RNA leading to increased mRNA and
protein production has also been shown in the case of car-
diac muscle-cell hypertrophy (Sano et al., 2002). On the other
hand, any alteration in nuclear speckle organization affects
transcription and pre-mRNA processing from a reporter
locus (Sacco-Bubulya and Spector, 2002). The changes in the
level of RNA pol II–mediated transcription as well as the
disorganization of speckle components, observed in the ab-
sence of 7SK RNA is likely interconnected. Recent studies
have provided evidence of bidirectional coupling between
transcriptional elongation and alternative splicing regula-
tion (Lin et al., 2008; Barboric et al., 2009). At the cellular as
well as organismal level, degradation of 7SK RNAs has been
shown to result in changes in alternative splicing of pre-
mRNAs (Barboric et al., 2009). It is speculated that upon
7SK-RNP degradation, the free pool of P-TEFb that is re-
leased from the inactive 7SK-RNP may promote alternative
splicing via phosphorylating the RNA Pol II CTD, which in
turn could facilitate enhanced binding of SR-family splicing
factors to pre-mRNAs (Lin and Fu, 2007; Barboric et al., 2009;
Long and Caceres, 2009; Zhong et al., 2009). A recent report
has indicated a role for the SC35 splicing factor in transcrip-
tion elongation, P-TEFb recruitment and RNA pol II CTD
ser-2 phosphorylation in a gene-speciﬁc manner, further
supporting the notion that splicing factors and transcription
elongation components interact with each other to regulate
gene expression (Lin et al., 2008).
7SK RNA has been shown to form an RNA-protein com-
plex consisting of HEXIM1 and 2, LARP7 and BCDIN3 and
P-TEFb (CDK9/Cyclin) to form an inactive P-TEFb complex
(Michels et al., 2004; Byers et al., 2005; Peterlin and Price,
2006; He et al., 2008; Krueger et al., 2008; Markert et al., 2008;
Michels and Bensaude, 2008; Barboric et al., 2009; Diribarne
and Bensaude, 2009) The active P-TEFb is composed of
CDK9 and one of the four c-types of Cyclins (Cyc-T1/
T2a(b)/K) (Zhou and Yik, 2006). LARP7 and BCDIN3 are
integral components of the 7SK-RNP complex and are es-
sential for the stability of 7SK snRNP complex (He et al.,
2008; Krueger et al., 2008; Barboric et al., 2009). The associa-
Figure 7. 7SK transiently accumulates at the
reporter gene locus during cessation of tran-
scription. Immunolocalization of CDK9
(green; Ab) and 7SK RNA FISH (red; Ac) in
representative U2OS 2-6-3 tet-OFF cells dem-
onstrates that at the marked locus (LacI-CFP,
blue; Aa) CDK9, but not 7SK RNA, is present
during active transcription (Aa–Ad). At 2 min
30s post Dox addition to turn the locus “OFF”
CDK9 (Bb) is still detectable at the locus (Ba)
and a slight enrichment in 7SK RNA (Bc) that
colocalizes with CDK9 (Bd) is now apparent.
Five minutes post-Dox perfusion 7SK RNA
(Cc) is now highly enriched at the locus (Ca)
and colocalizes strongly with CDK9 (Cd). At 7
min 30 s post-Dox perfusion, the marked
chromatin locus (Da) shows decrease in both
CDK9 (Db) and 7SK RNA (Dc) signals, with
only partial colocalization (Dd). By 10 min
post-Dox perfusion neither CDK9 (Eb) nor
7SK RNA (Ec) is present at the marked locus
(Ea). Scale bar represents 5 m.
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7SK RNA inactivates the kinase activity of CDK9, thereby
inhibiting the transcriptional elongation carried out by RNA
pol II (Peterlin and Price, 2006; Barrandon et al., 2007; Mich-
els and Bensaude, 2008). Two structurally different protein-
binding elements situated in the 5 and 3 terminal hairpins
Figure 8. 7SK RNA depletion affects the displacement of Cdk9 from the reporter gene locus during transcriptional silencing. Immunolocalization
of CDK9 (Ab; Aa–Ja) in U2OS 2-6-3 tet-OFF cells demonstrates that in the majority of control oligo treated cells (A–E), CDK9 is displaced within
10–15 min post DOX addition (Ca–c). However, in cells that are depleted of 7SK RNA (F–J) CDK9 continues to associate with the gene locus for
a longer duration of time post-DOX addition (H–I). DNA is counterstained with DAPI (Ac–Jc). The bar represents 5 m. (K) Histogram showing
reduced displacement of CDK9 from the gene locus in cells that are transfected with ASO against 7SK RNA (n  50). Scale bar represents 5 m.
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P-TEFb complex (Egloff et al., 2006). HEXIM proteins can
inhibit the kinase activity of P-TEFb only in the presence of
7SK RNA, indicating that 7SK RNA may act as a molecular
scaffold for the formation of the inactive P-TEFb complex
(Yik et al., 2003; Michels et al., 2004; Yik et al., 2004; Barboric
et al., 2005; Blazek et al., 2005; Byers et al., 2005; Yik et al.,
2005). However, information regarding the spatial context in
the nucleus where 7SK RNA interacts with HEXIM proteins
and the CDK9/CyclinT1 complex to form the inactive com-
plex has been lacking. Our data show an increased transient
accumulation of 7SK RNA in the vicinity of a gene locus
during its down-regulation, and this coincides with the loss
of CDK9 from the locus. Transient overexpression of 7SK
has been shown to inhibit transcription from a reporter
plasmid indicating the relative levels of 7SK RNA in cells are
crucial for proper gene expression (Egloff et al., 2006), and
our data have shown that knock-down of 7SK results in
increased transcription from a stably integrated reporter
locus. Increased local concentration of 7SK RNA observed in
the area of the gene locus during the cessation of transcrip-
tion may set up a concentration gradient to facilitate the
efﬁcient transfer of CDK9 from the gene to 7SK RNA thereby
down regulating gene expression. Changes in the displace-
ment of Cdk9 from the gene locus of cells that were depleted
of 7SK RNA further supports the notion that 7SK RNA plays
a critical role in the efﬁcient removal of P-TEFb components
from transcription sites. It remains to be demonstrated
whether HEXIM proteins and other components of the 7SK
snRNP complex are already bound to the pool of 7SK RNA
that is enriched at the gene locus during gene inactivation.
Previous studies have shown that both HEXIM1 and P-TEFb
interact at the 5 and 3 hairpins of 7SK RNA, respectively
and that 7SK RNA can interact with HEXIM1 without the
recruitment of P-TEFb (Egloff et al., 2006). Any alteration in
7SK RNA, which abolishes the binding of HEXIM1, also
inhibits the recruitment of P-TEFb to 7SK RNA (Egloff et al.,
2006). Similarly, in vitro reconstitution studies have revealed
that the binding of HEXIM1-7SK RNA is required for the
efﬁcient recruitment of P-TEFb to the 7SK RNA containing
complex (Michels et al., 2004). These results suggest that 7SK
RNA ﬁrst interacts with HEXIM proteins along with LARP7
and BCDIN3 and as a complex interacts with active P-TEFb.
From our data, it is tempting to speculate that 7SK RNA,
most probably as a complex with HEXIM proteins is re-
cruited to a gene during its down-regulation, facilitating the
efﬁcient removal of P-TEFb components and their recruit-
ment to nuclear speckles for storage/modiﬁcation. Thus,
nuclear speckles in turn may be involved in regulating gene
expression by modulating the levels of the active P-TEFb
complex in cells. Together, our ﬁndings have provided new
insight into the mechanism of action of 7SK RNA and nu-
clear speckles in regulating gene expression.
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